Merck divests Europe, Asia rights for ophthalmic products to Santen

By BC Staff | May 14, 2014 | 1:30 AM GMT

Merck & Co. Inc. (NYSE:MRK) will divest rights to nine ophthalmic products to Santen Pharmaceutical

Read the full 152 word article

How to gain access

Continue reading with a
two-week free trial.